What if there was a way to treat Type 1 Diabetes at its core, potentially restoring insulin production? Marylyn Rigby, Chief Communications Officer at Sernova, joins us to discuss the company's revolutionary approach to a "functional cure" for Type 1 Diabetes. We dive into the details of their Cell Pouch System, a cutting-edge technology that uses stem cells to restore insulin production and improve the quality of life for people with Type 1 Diabetes. Marylyn also shares exciting updates from recent clinical trials and gives us a glimpse into what’s next for Sernova. Tune in to learn how this groundbreaking treatment could change the future of diabetes care.